100 related articles for article (PubMed ID: 22531482)
21. Blue toe syndrome after initiation of low-dose oral anticoagulation.
Rauh G; Spengel FA
Eur J Med Res; 1998 Jun; 3(6):278-80. PubMed ID: 9620888
[TBL] [Abstract][Full Text] [Related]
22. Ambulatory therapy of patients with free-floating proximal deep vein thrombosis is safe.
Patel RK; Ramasamy K; Goss D; Deane C; Bonner L; Arya R
Thromb Haemost; 2005 Dec; 94(6):1343-4. PubMed ID: 16411421
[No Abstract] [Full Text] [Related]
23. Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis.
Warkentin TE; Whitlock RP; Teoh KH
Am J Hematol; 2004 Jan; 75(1):56-62. PubMed ID: 14695634
[TBL] [Abstract][Full Text] [Related]
24. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.
Turpie AG; Gallus AS; Hoek JA;
N Engl J Med; 2001 Mar; 344(9):619-25. PubMed ID: 11228275
[TBL] [Abstract][Full Text] [Related]
25. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
[TBL] [Abstract][Full Text] [Related]
26. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
[TBL] [Abstract][Full Text] [Related]
27. Dabigatran: new drug. Continue to use heparin, a better-known option.
Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
[TBL] [Abstract][Full Text] [Related]
28. Cholesterol crystal embolization caused by anticoagulant therapy.
Cortez AF; Sakuma TH; Lima RB; de Figueiredo WM; Valle Hde A; Tolstoy FA; Coimbra DD; Lupi O
Int J Dermatol; 2009 Sep; 48(9):989-90. PubMed ID: 19702986
[No Abstract] [Full Text] [Related]
29. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
[TBL] [Abstract][Full Text] [Related]
30. [The cost-effectiveness of fondaparinux compared to enoxaparin as prophylaxis for deep-vein thrombosis in Denmark].
Olsen J; Gundgaard J; Borris LC
Ugeskr Laeger; 2005 May; 167(21):2273-9. PubMed ID: 15962854
[No Abstract] [Full Text] [Related]
31. Unbalanced protein S deficiency due to warfarin treatment as a possible cause for thrombosis.
Haran MZ; Lichman I; Berebbi A; Weinmann E; Rosenberg N
Br J Haematol; 2007 Oct; 139(2):310-1. PubMed ID: 17897308
[TBL] [Abstract][Full Text] [Related]
32. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
[TBL] [Abstract][Full Text] [Related]
33. Oral rivaroxaban for symptomatic venous thromboembolism.
; Bauersachs R; Berkowitz SD; Brenner B; Buller HR; Decousus H; Gallus AS; Lensing AW; Misselwitz F; Prins MH; Raskob GE; Segers A; Verhamme P; Wells P; Agnelli G; Bounameaux H; Cohen A; Davidson BL; Piovella F; Schellong S
N Engl J Med; 2010 Dec; 363(26):2499-510. PubMed ID: 21128814
[TBL] [Abstract][Full Text] [Related]
34. Prolonged thromboprophylaxis with enoxaparin in early neurological rehabilitation.
Lang A; Kienitz C; Wetzel P; Rollnik JD
Clin Appl Thromb Hemost; 2011 Oct; 17(5):470-5. PubMed ID: 20547551
[TBL] [Abstract][Full Text] [Related]
35. A comparison of heparin/warfarin and enoxaparin thromboprophylaxis in spinal cord injury: the Sheffield experience.
Thumbikat P; Poonnoose PM; Balasubrahmaniam P; Ravichandran G; McClelland MR
Spinal Cord; 2002 Aug; 40(8):416-20. PubMed ID: 12124668
[TBL] [Abstract][Full Text] [Related]
36. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
[TBL] [Abstract][Full Text] [Related]
37. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.
Bergqvist D; Agnelli G; Cohen AT; Eldor A; Nilsson PE; Le Moigne-Amrani A; Dietrich-Neto F;
N Engl J Med; 2002 Mar; 346(13):975-80. PubMed ID: 11919306
[TBL] [Abstract][Full Text] [Related]
38. New protocols for perioperative management of podiatric patients taking oral anticoagulants.
Lanzat M; Danna AT; Jacobson DS
J Foot Ankle Surg; 1994; 33(1):16-20. PubMed ID: 8161987
[TBL] [Abstract][Full Text] [Related]
39. Blue toe syndrome caused by cholesterol crystal embolisation in a patient with warfarin use.
Kano Y; Shigehara Y
BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37798039
[No Abstract] [Full Text] [Related]
40. Cerebral sinus thrombosis in a child with active ulcerative colitis and factor V Leiden.
Robison NJ; Dawlabani N; Lastra CR; Dhall G
Pediatr Blood Cancer; 2009 Jul; 52(7):867-9. PubMed ID: 19260108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
